Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Trading Halts

Verrica Pharmaceuticals Inc. (VRCA) Reports First Patient Enrollment in Phase 2 Trial of VP-102 for the Treatment of External Genital WartsJune 27, 2019 4:03 PM Verrica Pharmaceuticals (VRCA) to Resume Trading at 4:30 pm ETJune 26, 2019 4:14 PM Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common WartsJune 26, 2019 4:01 PM